Curovic Rotbain Emelie, Lund Hansen Dennis, Schaffalitzky de Muckadell Ove, Wibrand Flemming, Meldgaard Lund Allan, Frederiksen Henrik
Department of Haematology, Odense University Hospital, Odense, Denmark.
Department of Medical Gastroenterology, Odense University Hospital, Odense, Denmark.
PLoS One. 2017 Nov 14;12(11):e0186674. doi: 10.1371/journal.pone.0186674. eCollection 2017.
Our aim was to assess the validity of the ICD-10 code for splenomegaly in the Danish National Registry of Patients (DNRP), as well as to investigate which underlying diseases explained the observed splenomegaly.
Splenomegaly is a common finding in patients referred to an internal medical department and can be caused by a large spectrum of diseases, including haematological diseases and liver cirrhosis. However, some patients remain without a causal diagnosis, despite extensive medical work-up.
We identified 129 patients through the DNRP, that had been given the ICD-10 splenomegaly diagnosis code in 1994-2013 at Odense University Hospital, Denmark, excluding patients with prior splenomegaly, malignant haematological neoplasia or liver cirrhosis. Medical records were reviewed for validity of the splenomegaly diagnosis, diagnostic work-up, and the underlying disease was determined. The positive predictive value (PPV) with 95% confidence interval (CI) was calculated for the splenomegaly diagnosis code. Patients with idiopathic splenomegaly in on-going follow-up were also invited to be investigated for Gaucher disease.
The overall PPV was 92% (95% CI: 85, 96). Haematological diseases were the underlying causal diagnosis in 39%; hepatic diseases in 18%, infectious disease in 10% and other diseases in 8%. 25% of patients with splenomegaly remained without a causal diagnosis. Lymphoma was the most common haematological causal diagnosis and liver cirrhosis the most common hepatic causal diagnosis. None of the investigated patients with idiopathic splenomegaly had Gaucher disease.
Our findings show that the splenomegaly diagnosis in the DNRP is valid and can be used in registry-based studies. However, because of suspected significant under-coding, it should be considered if supplementary data sources should be used in addition, in order to attain a more representative population. Haematological diseases were the most common cause, however in a large fraction of patients no causal diagnosis was found.
我们的目的是评估丹麦国家患者注册中心(DNRP)中脾脏肿大的国际疾病分类第十版(ICD - 10)编码的有效性,并调查哪些潜在疾病可解释观察到的脾脏肿大。
脾脏肿大在转诊至内科的患者中是常见发现,可由多种疾病引起,包括血液系统疾病和肝硬化。然而,尽管进行了广泛的医学检查,一些患者仍未得到病因诊断。
我们通过DNRP识别出129例患者,这些患者于1994年至2013年在丹麦欧登塞大学医院被给予ICD - 10脾脏肿大诊断编码,排除既往有脾脏肿大、恶性血液肿瘤或肝硬化的患者。查阅病历以评估脾脏肿大诊断的有效性、诊断检查情况,并确定潜在疾病。计算脾脏肿大诊断编码的阳性预测值(PPV)及95%置信区间(CI)。对正在接受随访的特发性脾脏肿大患者也邀请其进行戈谢病检查。
总体PPV为92%(95%CI:85,96)。血液系统疾病是39%患者的潜在病因诊断;肝脏疾病占18%,传染病占10%,其他疾病占8%。25%的脾脏肿大患者仍未得到病因诊断。淋巴瘤是最常见的血液系统病因诊断,肝硬化是最常见的肝脏病因诊断。所调查的特发性脾脏肿大患者中无一例患有戈谢病。
我们的研究结果表明,DNRP中的脾脏肿大诊断是有效的,可用于基于注册登记的研究。然而,由于怀疑存在显著的编码不足情况,应考虑是否还需使用补充数据源,以获得更具代表性的人群。血液系统疾病是最常见的病因,但很大一部分患者未找到病因诊断。